AGER and Alzheimer disease: Wang et al. (2014) administered Qifu-Yin (8.6–4.3 g/kg dayling for 30 days) to the mouse model of advanced glycation end product (AGE) induced AD, Donepezil (2 mg/kg) was administered as a positive control, and AGE + anti-advanced glycation end product receptor (anti-RAGE) were administered as an additional positive control group.